
Roivant Sciences Ltd.
USD34.96
+0.91 (+2.67%)
CEO
Matthew Gline
IPO Date
2020-12-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
GB
Open
$34.20
Prev. Close
$34.05
Day Low
$34.02
Day High
$35.24
52W Low
$10.90
52W High
$37.00
Market Cap
$25.15B
Volume
4.61M
| 21 May 2026 |
| HC Wainwright & Co. |
| Buy |
| Buy |
| maintain |
| 16 Apr 2026 | Piper Sandler | Overweight | Overweight | maintain |
| 4 Mar 2026 | HC Wainwright & Co. | Buy | Buy | maintain |
| 10 Feb 2026 | Citigroup | Buy | Buy | maintain |
| 10 Feb 2026 | HC Wainwright & Co. | Buy | Buy | maintain |
| 9 Feb 2026 | Guggenheim | Buy | Buy | maintain |
| 15 Dec 2025 | Goldman Sachs | Buy | Buy | maintain |